Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Cryptococcus neoformans var. neoformans B-3501A | Imidazoleglycerol-phosphate dehydratase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Probable imidazole glycerol-phosphate dehydratase HisB | Get druggable targets OG5_129258 | All targets in OG5_129258 |
Mycobacterium ulcerans | imidazoleglycerol-phosphate dehydratase | Get druggable targets OG5_129258 | All targets in OG5_129258 |
Mycobacterium leprae | Probable imidazole glycerol-phosphate dehydratase HisB | Get druggable targets OG5_129258 | All targets in OG5_129258 |
Candida albicans | Imidazole glycerol phosphate dehydratase | Get druggable targets OG5_129258 | All targets in OG5_129258 |
Candida albicans | Imidazole glycerol phosphate dehydratase | Get druggable targets OG5_129258 | All targets in OG5_129258 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Nanchung homolog | Imidazoleglycerol-phosphate dehydratase | 202 aa | 162 aa | 19.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0246 | 0.2574 | 0.6495 |
Mycobacterium leprae | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0337 | 0.3791 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0175 | 0.1615 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0125 | 0.0942 | 0.1116 |
Mycobacterium tuberculosis | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0683 | 0.8443 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0125 | 0.0942 | 0.1116 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0139 | 0.113 | 0.0657 |
Plasmodium falciparum | glutathione reductase | 0.0055 | 0 | 0.5 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0541 | 0.6527 | 0.6527 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0139 | 0.113 | 0.1338 |
Plasmodium vivax | glutathione reductase, putative | 0.0055 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.004 | 0.0247 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0165 | 0.1488 | 0.3755 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0541 | 0.6527 | 0.6527 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0799 | 1 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0165 | 0.1488 | 0.3755 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.004 | 0.0247 |
Mycobacterium ulcerans | imidazoleglycerol-phosphate dehydratase | 0.0683 | 0.8443 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0541 | 0.6527 | 0.6527 |
Leishmania major | hypothetical protein, conserved | 0.0246 | 0.2574 | 0.6495 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0125 | 0.0942 | 0.1116 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0799 | 1 | 1 |
Leishmania major | mitochondrial DNA polymerase beta | 0.035 | 0.3963 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.006 | 0.007 | 0.0176 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.035 | 0.3963 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0139 | 0.113 | 0.1338 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0058 | 0.004 | 0.0247 |
Brugia malayi | hypothetical protein | 0.0175 | 0.1615 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0058 | 0.004 | 0.0247 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0125 | 0.0942 | 0.1116 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0055 | 0 | 0.5 |
Echinococcus granulosus | neuropeptide s receptor | 0.0541 | 0.6527 | 0.6527 |
Toxoplasma gondii | hypothetical protein | 0.0056 | 0.0022 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0125 | 0.0942 | 0.1116 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.035 | 0.3963 | 1 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0165 | 0.1488 | 0.3755 |
Plasmodium falciparum | thioredoxin reductase | 0.0055 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0246 | 0.2574 | 0.6495 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0139 | 0.113 | 0.1338 |
Mycobacterium tuberculosis | Probable reductase | 0.0125 | 0.0942 | 0.1116 |
Onchocerca volvulus | 0.0175 | 0.1615 | 0.5 | |
Trypanosoma brucei | hypothetical protein, conserved | 0.0246 | 0.2574 | 0.6495 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.035 | 0.3963 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0184 | 0.1739 | 0.206 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.9 uM | Inhibitory concentration against imidazole glycerol phosphate dehydratase (IGPD) from Cryptococcus neoformans | ChEMBL. | 10450980 |
IC50 (binding) | = 3.9 uM | Inhibitory concentration against imidazole glycerol phosphate dehydratase (IGPD) from Cryptococcus neoformans | ChEMBL. | 10450980 |
Ki (binding) | = 0.8 uM | Binding affinity imidazole glycerol phosphate dehydratase (IGPD) obtained from Cryptococcus neoformans | ChEMBL. | 10450980 |
Ki (binding) | = 0.8 uM | Binding affinity imidazole glycerol phosphate dehydratase (IGPD) obtained from Cryptococcus neoformans | ChEMBL. | 10450980 |
Kis (binding) | = 6.1 uM | Kinetic constant for the inhibition of imidazole glycerol phosphate dehydratase (IGPD) | ChEMBL. | 10450980 |
Kis (binding) | = 6.1 uM | Kinetic constant for the inhibition of imidazole glycerol phosphate dehydratase (IGPD) | ChEMBL. | 10450980 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.